Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis

Ann Neurol. 2000 May;47(5):684-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Anti-Idiotypic / immunology*
  • Atrophy / immunology
  • Atrophy / pathology
  • Brain / immunology
  • Brain / pathology
  • Disease Progression
  • Gangliosides / immunology*
  • Humans
  • Immunoglobulin G / immunology
  • Immunoglobulin M / immunology
  • Magnetic Resonance Imaging
  • Multiple Sclerosis / immunology*
  • Multiple Sclerosis / pathology*

Substances

  • Antibodies, Anti-Idiotypic
  • Gangliosides
  • Immunoglobulin G
  • Immunoglobulin M